|
Quotes & Info
|
| IMUC > SEC Filings for IMUC > Form 8-K on 30-Jan-2013 | All Recent SEC Filings |
30-Jan-2013
Other Events
On January 29, 2013, ImmunoCellular Therapeutics, Ltd. (the "Company") issued a press release announcing that the US Food and Drug Administration has allowed the Company's investigational new drug application for ICT-140. A copy of the press release is attached hereto as Exhibit 99.1.
|
|